For further details refer to Note 8, Restructuring and other costs, in the Notes to Unaudited Consolidated Financial Statements of this Form 10-Q. Segment Adjusted Operating Income (a) See Note 6, Segment Information, in the Notes to Unaudited Consolidated Financial Statements in Item 1 of this Form 10-Q for a reconciliation from segment adjusted operating income to consolidated US GAAP income.For the quarter ended March 31, 2023, net sales in Russia and Ukraine were approximately 3% of our consolidated net sales, and net assets in these countries were $76 million.Partly due to these factors, sales declined by $14 million during the first quarter of 2023 relative to the first quarter of 2022.This reduction is compared to a distributor inventory build of approximately $10 million during the first quarter of 2023, which the Company notes represents a normal seasonal trend in dealer inventory levels.The increase of cash provided by financing activities compared to the first quarter of prior year was primarily driven by higher proceeds from short-term borrowings of $35 million.Key impacts for the three months ended March 31, 2023 are as follows: • As further described in the "Results of Operations" discussion below, we continue to experience supply chain challenges partly resulting from the pandemic including increased lead times, limited availability of certain components, raw material price increases, and higher procurement and shipping costs.Restructuring and Other CostsDuring the three months ended March 31, 2023, the Company recorded net expense of $59 million of restructuring and other costs which consist primarily of severance charges in conjunction with the restructuring plan announced in February 2023.40 Other Income and ExpenseNM-Not meaningfulInterest expense, netInterest expense, net for the three months ended March 31, 2023 increased compared to the three months ended March 31, 2022, driven primarily by higher interest rates on short-term and other borrowings.Other expense (income), netOther expense (income), net for the three months ended March 31, 2023 compared to the three months ended March 31, 2022 is as follows: (a) Foreign exchange losses (gains) are primarily related to the revaluation of intercompany payables and loans.DENTSPLY SIRONA Inc. and SubsidiariesItem 2–Management’ s Discussion and Analysis of Financial Condition and Results of OperationsInformation included in or incorporated by reference in this Form 10-Q, and other filings with the SEC and the Company’ s press releases or other public statements, contains or may contain forward-looking statements.Please refer to the discussion under the header“ Forward-Looking Statements and Associated Risks” in the forepart of this Form 10-Q. Company ProfileDENTSPLY SIRONA Inc. is the world's largest manufacturer of professional dental products and technologies, with a 136-year history of innovation and service to the dental industry and patients worldwide.For more information about the identified material weaknesses in internal control over financial reporting and the Company’ s remedial actions, please see Part I, Item 4 Controls and Procedures of this Form 10-Q. BUSINESSThe Company operates in two operating segments, Technologies & Equipment ("T & E") and Consumables.Refer to Part I, Item 1, Note 13, Goodwill and Intangible Assets, in the Notes to the Unaudited Consolidated Financial Statements of this Form 10-Q for further discussion of the Company's annual goodwill and indefinite-lived intangible asset impairment testing.At March 31, 2023, the Company held 52.0 million shares of treasury stock.At March 31, 2023, the Company had $21 million outstanding under short-term borrowing arrangements.At March 31, 2023, the Company was in compliance with these covenants.The restructuring plan anticipates a reduction in the Company’ s global workforce of approximately 8% to 10%, subject to co-determination processes with employee representative groups in countries where required.For further details refer to Note 8, Restructuring and other costs, in the Notes to Unaudited Consolidated Financial Statements of this Form 10-Q. Beginning in the second quarter of 2022, the Company's financial results have also been impacted by the costs associated with the internal investigation conducted by the Audit and Finance Committee and assisted by independent legal counsel and forensic accountants.Although the investigation has been completed at the time of this filing, related costs are expected to continue further into 2023 as the Company completes its remediation activities described in Part I, Item 4 Controls and Procedures of this Form 10-Q, and incurs legal defense costs pertaining to the matters described in Note 14 Commitments and Contingencies to the financial statements included in Part I, Item 1.